MedPath

Magrolimab

Generic Name
Magrolimab
Drug Type
Biotech
CAS Number
2169232-81-7
Unique Ingredient Identifier
90YIEHRFJ9

Overview

Magrolimab is under investigation in clinical trial NCT02953782 (Trial of Magrolimab (Hu5f9-g4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer).

Background

Magrolimab is under investigation in clinical trial NCT02953782 (Trial of Magrolimab (Hu5f9-g4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2024/08/06
Phase 1
Active, not recruiting
2024/08/01
Phase 1
Active, not recruiting
2023/09/21
Phase 2
Terminated
2023/07/03
Phase 2
Withdrawn
2023/04/28
Phase 2
Terminated
2023/04/25
Phase 2
Withdrawn
Uwe Platzbecker
2023/04/21
Phase 1
Suspended
City of Hope Medical Center
2023/02/21
Phase 1
Withdrawn
2022/11/25
N/A
NO_LONGER_AVAILABLE
2022/05/10
Phase 1
Withdrawn

FDA Approved Products

Product Name
Manufacturer
Route
Strength
Approved
NDC Code

No FDA products found

No FDA products found for this drug

EMA Approved Products

Product Name
EMA Number
Auth. Holder
Country
Drug Type
Status
Issued
Opinion
Revision

No EMA products found

No EMA products found for this drug

HSA Approved Products

Product Name
Manufacturer
Dosage Form
Strength
Approved
Approval Number

No HSA products found

No HSA products found for this drug

NMPA Approved Products

Product Name
Approval Number
Manufacturer
Dosage Form
Trade Name
Strength
Type
Status
Date
Import

No NMPA products found

No NMPA products found for this drug

PPB Approved Products

Product Name
Registration Code
Company
Category
Sale Type
Registration Date

No PPB products found

No PPB products found for this drug

TGA Approved Products

Product Name
ARTG ID
Sponsor
Status
Registration Date
Ingredient

No TGA products found

No TGA products found for this drug

© Copyright 2025. All Rights Reserved by MedPath